mRNA Is Never Naked, Exploring RBP Target Space & Therapeutic Opportunities

mRNA is never caught naked. RNA binding proteins (RBPs), act as vigilant guardians, covering RNA within cells. The role of RBPs is multifaceted, affecting mRNA processing, localization, life-time, and translation, working at steady state or leading to an instantaneous effect on their target mRNA upon stimuli. RBPs constitute an unexplored frontier, specifically implicated in different diseases including cancer, Neurodegeneration, and inflammation. Over the last decade, advancements in this novel target space have brought us to a juncture where the promise of these new therapeutic opportunities is greater than ever.

The following webinar features Dr. Iris Alroy, Co-Founder and Chief Scientific Officer, from Anima Biotech, and Dr. Kristopher Brannan, Assistant Professor and CPRIT Scholar in the Center for RNA Therapeutics and Houston Methodist Cancer Center at the Houston Methodist Research Institute. The following masterclass provides insights from our speakers that have made significant advancements in the field of RNA binding proteins.